An economic model to assess the savings from a clinical application of haematopoietic growth factors

This publication has 19 references indexed in Scilit:

• Peripheral blood progenitor cell transplantation mobilised by r-metHuG-CSF (Filgrastim); a Less costly alternative to autologous bone marrow transplantation
  European Journal Of Cancer, 1994
• Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
  New England Journal of Medicine, 1992
• Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF
  Blood, 1992
• Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
  New England Journal of Medicine, 1991
• Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever
  European Journal of Cancer and Clinical Oncology, 1990
• Effect of Granulocyte Colony-Stimulating Factor after Intensive Induction Therapy in Relapsed or Refractory Acute Leukemia
  New England Journal of Medicine, 1990
• The colony stimulating factors discovery, development, and clinical applications
  Cancer, 1990
• Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced Myelosuppression
  New England Journal of Medicine, 1988
• Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer
  British Journal of Cancer, 1987
• Granulocytopenia and cancer therapy: Past problems, current solutions, future challenges
  Cancer, 1984